Astrazeneca AZN Cash Flow Statement (2009-2026)

NYSE AZN
$165.98 +1.49 (+0.91%)
At close: Aug 21, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Sep2016 Dec2016 Jun2017 Dec2017 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-2.35B-0.93B0.72B0.13B0.20B0.65B2.72B2.36B1.93B7.00B3.42B2.87B2.22B1.83B3.88B2.88B3.95B2.93B4.75B2.60B
Cash from Discontinued Operations (Quarter)
1.72B1.42B3.23B1.25B7.41B3.13B1.72B7.96B2.49B3.08B3.38B2.91B3.71B3.39B5.13B2.34B3.36B
Gains from Sales and Divestitures (Quarter)
-0.02B-0.37B-0.01B-0.07B-0.09B-0.25B-0.25B-0.01B-0.06B-0.07B-0.02B-0.03B-0.05B-0.03B-0.09B
Gains from Investment Securities (Quarter)
-0.05B0.03B0.29B0.20B0.02B0.23B0.06B0.00B-0.03B0.00B-0.07B0.00B
Cash from Restructuring (Quarter)
Non-cash Items (Quarter)
2.56B-0.54B5.35B0.52B5.83B0.57B7.69B-0.20B-3.06B0.99B5.21B4.06B-1.19B-2.38B7.51B
Change in Working Capital (Quarter)
1.21B
Change in Accured Expenses (Quarter)
4.00B
Change in Taxes (Quarter)
-0.33B-0.55B-0.23B-0.78B-0.23B-0.84B-0.43B-0.91B-0.64B-0.77B-0.36B-1.19B-0.64B-0.65B-0.53B
Cash from Operations (Quarter)
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
2.79B2.19B1.31B1.36B4.00B1.50B1.28B4.06B1.25B1.28B1.82B2.34B1.28B1.39B1.55B1.51B1.37B
Investing Activities
Capital Expenditures (Quarter)
-0.26B1.86B-0.22B-0.25B-0.25B-0.27B-0.42B-0.38B-0.42B3.14B-0.43B1.52B-2.86B4.58B-0.55B1.86B
Sales of Property, Plant and Equipment (Quarter)
0.01B0.00B0.03B0.00B0.12B0.00B0.05B0.03B0.00B0.01B0.00B0.01B0.00B
Change in Intangibles (Quarter)
0.01B0.00B0.39B0.06B0.26B0.02B0.07B0.03B0.02B0.01B0.09B0.00B0.04B0.04B0.12B
Acquisitions (Quarter)
-24.83B5.76B-0.94B-0.19B-0.73B-2.04B5.23B1.83B-7.12B-0.01B7.56B
Change in Acquisitions & Divestments (Quarter)
-0.01B-0.02B0.02B-0.01B0.01B0.08B-0.06B0.10B0.03B-0.04B0.00B0.11B0.01B0.01B-0.09B0.04B
Cash from Investing Activities (Quarter)
-10.46B-0.91B-0.17B-0.80B-1.25B-0.52B-2.41B-2.87B-1.51B-1.18B-1.25B-2.11B-2.00B-1.45B-1.79B-2.91B
Financing Activities
Other financing activities (Quarter)
-0.08B-0.01B0.30B0.01B0.10B-0.03B1.00B1.50B-1.93B-0.60B1.10B0.64B-0.35B-1.02B2.33B
Cash from Financing Activities (Quarter)
-10.16B-5.60B-3.74B-1.29B-6.46B-2.03B-1.52B-6.57B2.03B-1.22B-4.13B-4.00B-2.71B0.52B-2.07B-3.28B0.27B-2.59B
Debt Issuance and Repayment
Net Debt Issuances and Repayments (Quarter)
3.06B0.45B4.70B1.89B1.20B4.98B0.07B0.21B1.87B1.73B2.46B1.28B3.13B0.90B1.57B
Change in Capital Stock
Net Shares Issued and Repurchased (Quarter)
Net Equity Issued and Repurchased (Quarter)
0.00B0.02B0.01B0.00B0.00B0.00B0.01B0.01B0.00B0.02B0.01B0.00B0.01B0.02B0.01B
Dividend Payments
Dividends Paid - Common (Quarter)
-1.39B7.71B-2.97B-3.05B-0.02B-3.03B-0.02B-1.58B9.26B-3.35B6.70B-8.32B9.94B-3.29B6.58B
Additional items
Exchange Rate Effect (Quarter)
-0.02B0.01B-0.01B-0.03B-0.01B-0.04B-0.05B-0.01B0.02B-0.06B0.03B0.03B-0.01B0.00B-0.02B0.01B
Change in Cash (Quarter)
-0.16B-8.99B-0.68B-0.85B-0.14B6.13B5.64B-4.54B4.54B-5.75B5.43B-3.88B3.88B-5.21B5.70B-6.50B
Free Cash Flow (Quarter)
0.26B-1.86B0.22B0.25B0.25B0.27B0.42B0.38B0.42B-3.14B0.43B-1.52B2.86B-4.58B0.55B-1.86B
Net Cash Flow (Quarter)
-20.62B-6.51B-3.91B-2.10B-6.46B-3.28B-2.04B-6.57B-0.39B-4.09B-5.64B-5.18B-3.96B-1.59B-4.07B-4.73B-1.52B-5.50B
Beginning Cash Balance (Quarter)